These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 39017880)

  • 1. Genomic Comparative of Pseudomonas aeruginosa Small Colony Variant, Mucoid and Non-mucoid Phenotypes Obtained from a Patient with Cystic Fibrosis During Respiratory Exacerbations.
    Almeida MM; Bastos LR; Firmida MC; Albano RM; Marques EA; Leão RS
    Curr Microbiol; 2024 Jul; 81(9):274. PubMed ID: 39017880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic determinants of antimicrobial resistance in polymyxin B resistant Pseudomonas aeruginosa isolated from airways of patients with cystic fibrosis.
    Simão FA; Almeida MM; Rosa HS; Marques EA; Leão RS
    Braz J Microbiol; 2024 Jun; 55(2):1415-1425. PubMed ID: 38619733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa Isolates From a Cohort of Mexican Children With Cystic Fibrosis Show Adaptation to a Chronic Phenotype.
    Rosales-Reyes R; Rodríguez-Alvarado M; Lezana-Fernández JL; Sánchez-Lozano JY; Gayosso-Vázquez C; Jarillo-Quijada MD; Toledano-Tableros JE; Arredondo-Mercado MJ; Alcántar-Curiel MD; Lincopan N; Vidal JE; Lascurain R; Valvano MA; Santos-Preciado JI
    Pediatr Infect Dis J; 2020 Oct; 39(10):899-906. PubMed ID: 32453200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genotypic and Phenotypic Diversity of Staphylococcus aureus Isolates from Cystic Fibrosis Patient Lung Infections and Their Interactions with Pseudomonas aeruginosa.
    Bernardy EE; Petit RA; Raghuram V; Alexander AM; Read TD; Goldberg JB
    mBio; 2020 Jun; 11(3):. PubMed ID: 32576671
    [No Abstract]   [Full Text] [Related]  

  • 6. Association of Diverse Staphylococcus aureus Populations with Pseudomonas aeruginosa Coinfection and Inflammation in Cystic Fibrosis Airway Infection.
    Wieneke MK; Dach F; Neumann C; Görlich D; Kaese L; Thißen T; Dübbers A; Kessler C; Große-Onnebrink J; Küster P; Schültingkemper H; Schwartbeck B; Roth J; Nofer JR; Treffon J; Posdorfer J; Boecken JM; Strake M; Abdo M; Westhues S; Kahl BC
    mSphere; 2021 Jun; 6(3):e0035821. PubMed ID: 34160233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimicrobial activity of tobramycin against respiratory cystic fibrosis Pseudomonas aeruginosa isolates from Bulgaria.
    Strateva T; Petrova G; Mitov I
    J Chemother; 2010 Dec; 22(6):378-83. PubMed ID: 21303744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic shift in Pseudomonas aeruginosa populations from cystic fibrosis lungs after 2-week antipseudomonal treatment.
    Fernández-Barat L; Ciofu O; Kragh KN; Pressler T; Johansen U; Motos A; Torres A; Hoiby N
    J Cyst Fibros; 2017 Mar; 16(2):222-229. PubMed ID: 27651273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombination is a key driver of genomic and phenotypic diversity in a Pseudomonas aeruginosa population during cystic fibrosis infection.
    Darch SE; McNally A; Harrison F; Corander J; Barr HL; Paszkiewicz K; Holden S; Fogarty A; Crusz SA; Diggle SP
    Sci Rep; 2015 Jan; 5():7649. PubMed ID: 25578031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the early events of Pseudomonas aeruginosa adaptation in cystic fibrosis airway environment using a long-term in vitro maintenance.
    Sousa AM; Monteiro R; Pereira MO
    Int J Med Microbiol; 2018 Dec; 308(8):1053-1064. PubMed ID: 30377031
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integron types, antimicrobial resistance genes, virulence gene profile, alginate production and biofilm formation in Iranian cystic fibrosis Pseudomonas aeruginosa isolates.
    Pournajaf A; Razavi S; Irajian G; Ardebili A; Erfani Y; Solgi S; Yaghoubi S; Rasaeian A; Yahyapour Y; Kafshgari R; Shoja S; Rajabnia R
    Infez Med; 2018 Sep; 26(3):226-236. PubMed ID: 30246765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of hypermutable Pseudomonas aeruginosa in cystic fibrosis patients is associated with the oxidative stress caused by chronic lung inflammation.
    Ciofu O; Riis B; Pressler T; Poulsen HE; Høiby N
    Antimicrob Agents Chemother; 2005 Jun; 49(6):2276-82. PubMed ID: 15917521
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of Hypermutator Pseudomonas aeruginosa Isolates from Patients with Cystic Fibrosis in Australia.
    Rees VE; Deveson Lucas DS; López-Causapé C; Huang Y; Kotsimbos T; Bulitta JB; Rees MC; Barugahare A; Peleg AY; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
    Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Staphylococcus aureus in the airways of cystic fibrosis patients - A retrospective long-term study.
    Schwerdt M; Neumann C; Schwartbeck B; Kampmeier S; Herzog S; Görlich D; Dübbers A; Große-Onnebrink J; Kessler C; Küster P; Schültingkemper H; Treffon J; Peters G; Kahl BC
    Int J Med Microbiol; 2018 Aug; 308(6):631-639. PubMed ID: 29501453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Presence of pldA and exoU in mucoid Pseudomonas aeruginosa is associated with high risk of exacerbations in non-cystic fibrosis bronchiectasis patients.
    Luo RG; Miao XY; Luo LL; Mao B; Yu FY; Xu JF
    Clin Microbiol Infect; 2019 May; 25(5):601-606. PubMed ID: 30036669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic and Functional Characterization of Longitudinal Pseudomonas aeruginosa Isolates from Young Patients with Cystic Fibrosis.
    Chandler CE; Hofstaedter CE; Hazen TH; Rasko DA; Ernst RK
    Microbiol Spectr; 2023 Aug; 11(4):e0155623. PubMed ID: 37358436
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic effects of inhaled aztreonam plus tobramycin on hypermutable cystic fibrosis Pseudomonas aeruginosa isolates in a dynamic biofilm model evaluated by mechanism-based modelling and whole genome sequencing.
    Breen SKJ; Harper M; López-Causapé C; Rogers KE; Tait JR; Smallman TR; Lang Y; Lee WL; Zhou J; Zhang Y; Bulitta JB; Nation RL; Oliver A; Boyce JD; Landersdorfer CB
    Int J Antimicrob Agents; 2024 Jun; 63(6):107161. PubMed ID: 38561094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.
    Mayer-Hamblett N; Rosenfeld M; Gibson RL; Ramsey BW; Kulasekara HD; Retsch-Bogart GZ; Morgan W; Wolter DJ; Pope CE; Houston LS; Kulasekara BR; Khan U; Burns JL; Miller SI; Hoffman LR
    Am J Respir Crit Care Med; 2014 Aug; 190(3):289-97. PubMed ID: 24937177
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective Sweeps and Parallel Pathoadaptation Drive Pseudomonas aeruginosa Evolution in the Cystic Fibrosis Lung.
    Diaz Caballero J; Clark ST; Coburn B; Zhang Y; Wang PW; Donaldson SL; Tullis DE; Yau YC; Waters VJ; Hwang DM; Guttman DS
    mBio; 2015 Sep; 6(5):e00981-15. PubMed ID: 26330513
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation of the algT operon sequence in mucoid and non-mucoid Pseudomonas aeruginosa isolates from 115 Scandinavian patients with cystic fibrosis and in 88 in vitro non-mucoid revertants.
    Ciofu O; Lee B; Johannesson M; Hermansen NO; Meyer P; Høiby N
    Microbiology (Reading); 2008 Jan; 154(Pt 1):103-113. PubMed ID: 18174130
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.